Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? G.N. Pongas, R.E.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Gut bacterial microbiota and obesity

Approach to diagnosis of infective endocarditis

S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler

Herpes zoster in non-hospitalized children

Migrant health—a cause for concern?

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Hepatitis B and C virus-related carcinogenesis

Infectious causes of cancer: an evolving educational saga

Refugee crisis and re-emergence of forgotten infections in Europe

R. Cantón Clinical Microbiology and Infection

Genital Chlamydia trachomatis infections

P. Nordmann, L. Poirel Clinical Microbiology and Infection

Public health significance of invasive mosquitoes in Europe

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Non-antibiotic strategies for sepsis

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

J.P. Donnelly, B.E. De Pauw Clinical Microbiology and Infection

Oral versus intravenous therapy in the treatment of systemic mycosis

Training for the infectious diseases speciality in Norway

B. Gordts Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Elements of design: the knowledge on which we build

Levofloxacin in the treatment of ventilator-associated pneumonia

G. Pappas Clinical Microbiology and Infection

Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study M.R. Berndsen,

Metagenomics and probiotics

Hepatitis B and C virus-related carcinogenesis

Laboratory diagnosis of Clostridium difficile disease

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

The practice of travel medicine in Europe

T.M. File Clinical Microbiology and Infection

Update on antifungal resistance in Aspergillus and Candida

Antibacterial drug discovery in the 21st century

Abstracts cont. Clinical Microbiology and Infection

Pandemic lineages of extraintestinal pathogenic Escherichia coli

Current experience in treating invasive zygomycosis with posaconazole

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

A.P. Underwood, J. Green Clinical Microbiology and Infection

Antimicrobial drug development – the past, the present, and the future

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Listeriosis: a resurgent foodborne infection

Clinical Microbiology and Infection

Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria E. Presterl, F. Daxböck, W. Graninger,

Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis

Leishmaniasis in immunosuppressed individuals

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

Z. Erjavec, H. Kluin-Nelemans, P.E. Verweij

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

Comparative study of pediculicidal effect of medical plants

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? G.N. Pongas, R.E. Lewis, G. Samonis, D.P. Kontoyiannis Clinical Microbiology and Infection Volume 15, Pages 93-97 (January 2009) DOI: 10.1111/j.1469-0691.2009.02988.x Copyright © 2009 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

FIG. 1 Possible epigenetic mechanisms of increased virulence in Rhizopus oryzae following voriconazole exposure. Clinical Microbiology and Infection 2009 15, 93-97DOI: (10.1111/j.1469-0691.2009.02988.x) Copyright © 2009 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions